Robotic Surgery Will Explode: Buy This Healthcare Stock Before Its 50% Run.

Intuitive Surgical (ISRG), a growth stock known for its da Vinci surgical robots, is positioned for significant upside, potentially 50% or more, despite its historical drawdowns. The company's core business remains robust, with Q3 2025 seeing 427 new robot installations and a 20% year-over-year increase in procedures, driving substantial annuity-like revenue from instruments and services across its 10,763 global systems. A key long-term growth catalyst is its strategic integration of AI, which, while currently in early stages, could eventually enable autonomous surgical capabilities, further expanding its market and utilization.

Analysis

Intuitive Surgical (ISRG) is identified as a growth stock with significant upside potential, projected at 50% or more, despite its history of experiencing drawdowns exceeding 30%. The company's operational performance remains strong, evidenced by 427 da Vinci robot installations in Q3 2025, an increase from 329 in Q3 2024, and a 20% year-over-year rise in procedures. This robust activity drives the annuity-like sales of instruments, accessories, and services, which constitute approximately 75% of the company's top-line revenue.
The long-term growth trajectory for ISRG is increasingly tied to its strategic integration of Artificial Intelligence (AI). While fully autonomous AI surgery is a distant prospect, the company is already incorporating AI into its products in smaller capacities. This foundational work positions Intuitive Surgical to potentially leverage its extensive installed base of 10,763 da Vinci robots globally for future AI-driven procedural expansion.
The potential for AI to eventually handle more routine procedures could significantly expand the market for robotic surgery, further increasing demand for da Vinci systems and their associated high-margin parts and services. This future AI-driven growth is a key factor that could propel the stock higher, building upon its established leadership in robotic surgical systems and strong recurring revenue model.

Key Decisions for Investors

• Monitor Intuitive Surgical's quarterly reports for continued growth in robot installations and procedure volumes, as these are critical drivers of its high-margin recurring revenue stream.
• Assess the company's progress in AI integration and its potential to unlock new market opportunities and operational efficiencies, recognizing that AI-driven autonomous surgery represents a significant long-term catalyst.
• Consider ISRG for long-term growth portfolios, acknowledging its historical stock volatility and current valuation, but focusing on its strong fundamental business model and future expansion potential through technological advancements like AI.